BrainsWay Reports Third Quarter 2024 Financial Results and …

3 days ago  · Robust 26% Year-over-Year Revenue Growth in Q3 2024 Raising Full-Year 2024 Revenue Guidance to $40-41 Million and Initiating Profitability Guidance Conference Call to be …


Install CouponFollow Chrome Extension   CouponFollow Extension

26%
OFF

BrainsWay Reports Third Quarter 2024 Financial Results And …

2 weeks from now

3 days ago  · Robust 26% Year-over-Year Revenue Growth in Q3 2024 Raising Full-Year 2024 Revenue Guidance to $40-41 Million and Initiating Profitability Guidance Conference Call to be …

brainsway.com

26%
OFF

BrainsWay Reports Strong Q3 2024 Revenue Growth - Markets …

2 weeks from now

2 days ago  · In its latest earnings release for the third quarter of 2024, BrainsWay reported impressive financial growth, with a 26% increase in revenue year-over-year reaching $10.5 …

businessinsider.com

26%
OFF

BrainsWay Reports Third Quarter 2024 Financial Results And

2 weeks from now

3 days ago  · Robust 26% Year-over-Year Revenue Growth in Q3 2024. Raising Full-Year 2024 Revenue Guidance to $40-41 Million and Initiating Profitability Guidance. Conference Call to …

nasdaq.com

26%
OFF

BrainsWay Ltd (BRSYF) Q3 2024 Earnings Call Highlights: Strong …

2 weeks from now

Revenue: $10.5 million for Q3 2024, a 26% increase year-over-year. Gross Margin: 74% for Q3 2024, consistent with the prior-year period. Net Income: Approximately $650,000 for Q3 2024, …

yahoo.com

26%
OFF

Earnings Call: BrainsWay Reports Strong Revenue Growth In Q3 2024

2 weeks from now

2 days ago  · BrainsWay (BWAY), a leading provider of brain health treatments, has announced a significant 26% increase in year-over-year revenue, reaching $10.5 million for the third quarter …

investing.com

26%
OFF

BrainsWay Ltd. (BWAY) Q3 2024 Earnings Call Transcript

2 weeks from now

3 days ago  · Most importantly, global market demand for our industry-leading Deep TMS system continues to be strong and led to a year-over-year increase of 26% in revenue to a $10.5 …

seekingalpha.com

26%
OFF

BrainsWay’s Strong Q3 Growth And Strategic Expansion - Markets …

2 weeks from now

3 days ago  · Brainsway has released an update.BrainsWay reported a strong 26% revenue growth in Q3 2024, raising its full-year revenue guidance to $40-41 million and achieving net …

businessinsider.com

$13.40
OFF

Brainsway Price Target Raised To $13.40 From $12.60 At Ladenburg

2 weeks from now

2 days ago  · BrainsWay Reports Strong Q3 2024 Revenue Growth; BrainsWay’s Strong Q3 Growth and Strategic Expansion; Brainsway reports Q3 EPS 2c, consensus 1c; Brainsway …

nasdaq.com

28%
OFF

BrainsWay Reports Second Quarter 2024 Financial Results And …

2 weeks from now

“Market demand for our Deep TMS system continued to increase during the second quarter of 2024, driving 28% revenue growth year-over-year. In addition, we generated positive quarterly …

brainsway.com

6%
OFF

Airgain Inc (AIRG) Q3 2024 Earnings Call Highlights: Strong …

2 weeks from now

2 days ago  · Airgain Inc (NASDAQ:AIRG) achieved strong sequential revenue growth with sales of $16.1 million, a 6% increase over the second quarter. The company reported robust sales in …

yahoo.com

2%
OFF

MaxCyte Inc (MXCT) Q3 2024 Earnings Call Highlights: Strong Core ...

2 weeks from now

Nov 7, 2024  · Total Revenue: $8.2 million in Q3 2024, a 2% increase from $8 million in Q3 2023. Core Revenue: $8.1 million, up 23% from $6.6 million in the prior year quarter. Cell Therapy …

yahoo.com

6%
OFF

CI&T Reports Strong Revenue Growth In Q3 2024 | Markets Insider

2 weeks from now

20 hours ago  · In its latest earnings report for the third quarter of 2024, CI&T reported a record net revenue of R$ 622.2 million, a 17.6% increase compared to the same period in 2023, with a …

businessinsider.com

$0.46
OFF

Trinity Biotech Announces Q3 2024 Financial Results

2 weeks from now

6 hours ago  · The basic and diluted loss per ADS for Q3 2024 was $0.46 compared to $1.55 in Q3 2023. Liquidity. The Group’s cash balance decreased to $2.8m at the end of Q3 2024 from …

globenewswire.com

26%
OFF

BrainsWay Q3 Revenue Surges 26% To $10.5M, Raises 2024 …

2 weeks from now

3 days ago  · BrainsWay's Q3 2024 results demonstrate robust growth and improving profitability metrics. Revenue grew 26% YoY to $10.5 million, with strong gross margins of 74%.The …

stocktitan.net

3%
OFF

Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript

2 weeks from now

20 hours ago  · Starting with our revenue, our revenues for Q3 2024 were $15.2 million which is just over 3% higher than Q3 2023. Our point-of-care revenue continues to have a large impact …

seekingalpha.com

$0.46
OFF

Trinity Biotech Announces Q3 2024 Financial Results

2 weeks from now

6 hours ago  · The basic and diluted loss per ADS for Q3 2024 was $0.46 compared to $1.55 in Q3 2023.. Liquidity. The Group’s cash balance decreased to $2.8m at the end of Q3 2024 …

marketscreener.com

6%
OFF

Trinity Biotech Announces Q3 2024 Financial Results - Markets …

2 weeks from now

6 hours ago  · Our clinical laboratory revenue was $10.8m in Q3 2024, a decrease of $1.2m or 9.6% compared to $12.0m in Q3 2023. There was a strong performance in the quarter from …

businessinsider.com

26%
OFF

Earnings Call: BrainsWay Reports Strong Revenue Growth In Q3 2024

2 weeks from now

Most importantly, global market demand for our industry-leading Deep TMS system continues to be strong and led to a year-over-year increase of 26% in revenue to a $10.5 million for the third ...

investing.com

FAQs about BrainsWay Reports Third Quarter 2024 Financial Results and … Coupon?

How did Brainsway perform in the third quarter of 2024?

The company, with operations in Burlington, MA and Jerusalem, Israel, focuses on advancing mental health treatments through innovative technology and clinical research. In its latest earnings release for the third quarter of 2024, BrainsWay reported impressive financial growth, with a 26% increase in revenue year-over-year reaching $10.5 million. ...

What is Brainsway's revenue guidance for 2024?

Looking ahead, BrainsWay has raised its full-year 2024 revenue guidance to $40-41 million, reflecting anticipated growth of 25% to 29% over the previous year. ...

Is Brainsway a good stock to buy in 2024?

BrainsWay’s increased revenue guidance for 2024, reflecting a 25% to 29% growth over 2023, alongside expectations for continued profitability and positive cash flow, underscores the company’s strong market position. ...

What information did Brainsway present to its investors?

Here is a breakdown of the information Brainsway presented to its investors. BrainsWay, a global leader in noninvasive neurostimulation treatments for mental health disorders, reported strong financial results for the third quarter of 2024, demonstrating significant growth and operational milestones. ...

What was the net profit in Q3 2024?

Gross profit for the quarter was $5.3m and gross margin for Q3 2024 was 35.0%. Gross margin was broadly in line with Q3 2023 when excluding stock obsolescence charges. ...

What was our clinical laboratory revenue in Q3 2024?

Our clinical laboratory revenue was $10.8m in Q3 2024, a decrease of $1.2m or 9.6% compared to $12.0m in Q3 2023. There was a strong performance in the quarter from our clinical chemistry portfolio which grew 79.3% year-over-year. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension